Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01152918 · ClinicalTrials.gov registry record · NA
Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies
A NA study, sponsored by HIV Prevention Trials Network.
- Completed
- Registry status
- NA
- Development phase
- 18,442
- Enrollment target
NCT01152918 is a NA study that has completed, run by HIV Prevention Trials Network. The registered enrollment target is 18,442 participants.
The verdict
NCT01152918, a NA study, has completed, sponsored by HIV Prevention Trials Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 18,442 participants
- Enrollment target
Study Summary
This is a five-part study that will take place in the Bronx, New York (NY), and Washington, District of Columbia (DC). The different components of the study will focus on increasing the number of people being tested for HIV, evaluating ways to link HIV-infected people to HIV care sites, evaluating methods to reinforce antiretroviral therapy (ART) adherence, and evaluating a counseling program that focuses on HIV prevention. (Details for only three components of this study are included in ClinicalTrials.gov (Linkage-to-Care, Viral Suppression and Prevention for Positives) because they are the only ones that were randomized and had prescriptive interventions.)
Interventions
- BEHAVIORAL Linkage-to-Care Component: Financial Incentive (FI)
- BEHAVIORAL Linkage-to-Care Component: Standard of Care (SOC)
- BEHAVIORAL Viral Suppression Component: FI
- BEHAVIORAL Viral Suppression Component: SOC
- BEHAVIORAL Prevention for Positives Component: Counseling and SOC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18,442 participants |
| Start Date | 2010-09 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01152918
The ClinicalTrials.gov registry entry for NCT01152918 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18,442 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is HIV Prevention Trials Network, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Linkage-to-Care Component: Financial Incentive (FI) is the first listed.
NCT01152918 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01152918 about?
NCT01152918 is a clinical study titled "Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies". This is a five-part study that will take place in the Bronx, New York (NY), and Washington, District of Columbia (DC). The different components of the study will focus on increasing the number of people being tested for HIV, evaluating ways to link HIV-infected people to HIV care sites, evaluating m...
What is the current status of trial NCT01152918?
This trial is currently completed. It is a NA study. The enrollment target is 18,442 participants. The study started on 2010-09. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01152918?
The interventions under investigation include: Linkage-to-Care Component: Financial Incentive (FI) (BEHAVIORAL), Linkage-to-Care Component: Standard of Care (SOC) (BEHAVIORAL), Viral Suppression Component: FI (BEHAVIORAL), Viral Suppression Component: SOC (BEHAVIORAL), Prevention for Positives Component: Counseling and SOC (BEHAVIORAL).
Who is sponsoring clinical trial NCT01152918?
This trial is sponsored by HIV Prevention Trials Network, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.